SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: sam who wrote (2468)10/24/1997 11:32:00 AM
From: Joe E.  Read Replies (3) | Respond to of 6136
 
Re Dr. Gallo's chemokines:

Another far-off in the future treatment for AIDS. Pray that it works.

Has essentially no longterm investment impact on AGPH, IMO, as Viracept should by then have been supplanted as one of the leading treatments for the disease. AGPH by then should have a stable of drugs, much like Merck (well, maybe smaller).

May provide a short term buying opportunity, if it gets sufficient media attention this weekend.



To: sam who wrote (2468)10/24/1997 2:58:00 PM
From: billkirn  Respond to of 6136
 
Sam: For the sake of the HIV community lets hope this helps.
I have a feeling it will become another tool to fight this virus. Studies to see if it really works in humans is 2 years out and then maybe another few years before market approval.

The PI's will be used for a long long time.

Bill


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News